CompletedPhase 2NCT03984370
Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass
Studying Congenital isolated hyperinsulinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Gentofte, Copenhagen
- Principal Investigator
- Filip M. Knop, Prof., MDHerlev-Gentofte Hospital, Center for Clinical Metabolic Research
- Intervention
- ZP4207(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2019 – 2020
Study locations (1)
- Center for Clinical Metabolic Research, Herlev-Gentofte Hospital, Hellerup, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03984370 on ClinicalTrials.gov